GLP-1 weight-loss drug, whose full name is Glucagon-like peptide-1 receptor agonist. Initially, GLP-1 was a hormone secreted by the gastrointestinal tract mainly used for treating diabetes, but it has also been used to suppress appetite and control weight.
Viking Therapeutics Stock On Brink Of Death Cross As Weight Loss Hype Loses Momentum
Wednesday Ends With Index Decline | Wall Street Today
Wolfe's Short Ideas: Companies With Potential Dividend Cuts
Short Stock Ideas From Each Sector With Earnings Quality in the Bottom 20%
RBC Capital Maintains Outperform on Amgen, Lowers Price Target to $330
Amgen Analyst Ratings